Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$257.1M
-30.4% from 2023
Prescriptions
40K
$6,355.61 per claim
Patients
4,784
3,250 prescribers
Total spending, 2024
$257.2M
$53,742.48 per patient
Medicare prescription drug plans paid $257.1M for Copaxone in 2024, for 40,447 prescriptions and refills to 4,784 patients (down 30.4% from 2023). The average cost per claim was $6,355.61.
New York had the highest Medicare cost for Copaxone in 2024: $23.6M for 3,488 claims, followed by Pennsylvania ($21.9M).
Clyde E Markowitz, neurology in Philadelphia, PA, had the highest Medicare cost for Copaxone in 2024: 255 claims costing $1.7M.
Copaxone is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva Neuroscien.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Clyde E Markowitz Philadelphia, PA | Neurology | 255 | 33 | $1.7M |
| Mary Ann Picone Teaneck, NJ | Neurology | 224 | 30 | $1.6M |
| Mirela Cerghet Detroit, MI |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,556 | 67,049 | 7,922 | $456.5M |
| 2023 | 3,974 | 54,286 | 6,382 | $369.2M |
| 2024 | 3,250 | 40,447 | 4,784 | $257.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 193 |
| 23 |
| $1.2M |
| Ben W Thrower Atlanta, GA | Neurology | 182 | 20 | $1.1M |
| Daniel S Bandari Newport Beach, CA | Neurology | 161 | 15 | $1.0M |
| Donald A Barone Camden, NJ | Neurology | 130 | 16 | $887K |
| Hart C Cohen Los Angeles, CA | Neurology | 146 | 14 | $856K |
| Gary A Thomas Hershey, PA | Neurology | 109 | 16 | $815K |
| Donald Negroski Sarasota, FL | Neurology | 109 | Under 11 | $778K |
| Sara S Qureshi Billings, MT | Neurology | 130 | 14 | $767K |
| Brian Steingo Boca Raton, FL | Neurology | 127 | 14 | $763K |
| Erica Grazioli Erie, PA | Neurology | 119 | 15 | $716K |
| Teresa M Deangelis New York, NY | Neurology | 93 | Under 11 | $707K |
| Richard H Blanck Lake Success, NY | Neurology | 81 | 14 | $693K |
| Sherrill R Loring Atlanta, GA | Neurology | 101 | 15 | $673K |
| Anastasia M Lyras New York, NY | Nurse Practitioner | 92 | 15 | $666K |
| Shelly L Larson-Peters Blaine, MN | Neurology | 110 | 12 | $660K |
| Jacob A Sloane Boston, MA | Neurology | 105 | 11 | $632K |
| Joseph B Guarnaccia Derby, CT | Neurology | 100 | 11 | $629K |
| Jean B Cain Allentown, PA | Nurse Practitioner | 92 | 14 | $629K |
| Brian R Apatoff New York, NY | Neurology | 86 | Under 11 | $616K |
| Andrew Bierman Irvine, CA | Nurse Practitioner | 103 | 16 | $613K |
| Timothy J Carrabine Uniontown, OH | Internal Medicine | 104 | 11 | $609K |
| Evanthia Bernitsas Detroit, MI | Neurology | 88 | 12 | $586K |
| Ruth K Fredericks Jackson, MS | Neurology | 90 | 12 | $571K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva Neuroscien TEVA | 40,460 | $257.2M |